Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid... see more

TSXV:MIR - Post Discussion

MedMira Inc > -Medmira's miracle ? VYRA CoV2Flu
View:
Post by goldyhawk on Mar 05, 2022 4:59pm

-Medmira's miracle ? VYRA CoV2Flu

The test simultaneously detects the nucleocapsid antigens of SARS-CoV-2, influenza A and B. Three different results can be achieved in a few minutes. The test has demonstrated that it can detect influenza A and B viruses from a test panel containing influenza A (Brisbane/59/07, Brisbane/10/07, Perth/16/2009, Solomon Islands/03 /2006, New Caledonia/20/99, Swine NY/01/2009 and Swine Canada/6294/09) and influenza B (Lee/40, Florida/02/2006, Brisbane/33/2008 and Panama/45/90 ) includes. These positive samples were all confirmed by rapid influenza tests approved by the Food and Drug Administration.

"We are confident that our VYRA CoV2Flu product will meet customers' needs for

Comment by conservative2 on Mar 05, 2022 9:29pm
I believe that VYRA CoV2Flu product will be the solution to Medmira's cash flow issues of the past.  This combination test will WIN THE DAY and provide the world with a means of identifying symtoms of the Flu or covid at the same time!! Just this week, our son in law had all the symptoms of covid, but tested negetive in all covid tests.  It seems as if the flu is still alive and ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities